Table 1.
The demographic and clinical parameters of 139 patients.
| Variable | |
|---|---|
| Age (years) (mean ± SD) | 52.6 ± 15.7 |
| Sex (male/female) (n:) | 67/72 |
| BMI (kg/m2) (mean ± SD) | 28.9 ± 5.9 |
| Type 2 diabetes (present/absent) (n:) | 57/82 |
| Smoking (present/absent) (n:) | 30/109 |
| Presence of CAD (n:) | 18/121 |
| Use of ACE inhibitor (present/absent) (n:) | 27/112 |
| Use of calcium channel blocker (CCB) (present/absent) (n:) | 27/112 |
| Use of β-blocker (present/absent) (n:) | 25/114 |
| Use of α-blocker (present/absent) (n:) | 4/135 |
| Use of diuretic (present/absent) (n:) | 21/118 |
| Use of AT2 blocker (present/absent) (n:) | 37/102 |
| Use of spironolactone (present/absent) (n:) | 8/131 |
| Office systolic blood pressure (SBP) (mmHg) (mean ± SD) | 132.3 ± 16.9 |
| Office DBP (mmHg) (mean ± SD) | 81.15 ± 9.8 |
SD: standard deviation; BMI: body mass index; CAD: coronary artery disease; ACE: angiotensin converting enzyme; CCB: calcium channel blocker; β: beta-Adrenergic; α: alpha-adrenergic; AT2: angiotensin receptor blocker; SBP: systolic blood pressure; DBP: diastolic blood pressure.